Anavex Life Sciences Corp (AVXL)

[Gator328]

That's one way to look at it. But I see something different.

I see a CEO who has navigated a difficult path. Over the past 7 years there have been countless hit pieces and short attacks, numerous baseless allegations and frivolous lawsuits, a pandemic, a recession and several competitors' drugs biting the dust to get the company to where it is today: front and center at CTAD 2022 presenting data about a novel MOA for treating Alzheimer's disease.

And the company has something like $149 million in cash and minimal debt. This is an enviable financial position any biotech startup CFO would love to inherit.

Dr. Missling isn't perfect but he's done a good job of putting Anavex in a position to succeed. He took some bold risks not attempting to partner with anyone too early on, and in three days we find out if he made the right decision.

I don't know what the data will be, but I am almost certain at worst it'll be neutral and that's a win for me. I'm not in any hurry and if the stock price drops while they run another trial, so be it. I've owned the stock for 100 months, what's another 18-24?